The global multiplexed diagnostics market attained a value of USD 14.86 Billion in 2025. The market is further expected to grow in the forecast period of 2026-2035 at a CAGR of 15.20%, to reach USD 61.17 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
15.2%
Value in USD Billion
2026-2035
*this image is indicative*
Multiplexing is the process of identifying or detecting multiple biomarkers at the same time in a single diagnostic test. Multiplexed diagnostics are highly valuable in certain disease types such as cardiovascular and infectious diseases to detect relevant biomarkers and guide the most optimal treatment plan. The clinically available multiplex diagnostics typically offer services to detect peptide or protein biomarkers and nucleic acid testing.
The rise in the prevalence of chronic disease directly impacts the multiplexed diagnostics market demand positively. Recent data suggests that chronic diseases are responsible for the mortality of 41 million people annually, which accounts for 74% of all deaths globally. Cardiovascular diseases account for most of the deaths in the chronic diseases category, reported to be 17.9 million in a year. To tackle the rising burden of chronic diseases and associated mortality, there is an increased emphasis on the development of multiplexed diagnostics to get actionable health insights in less time and cost.
The surge in approvals of multiplexed diagnostic platforms by health regulatory agencies such as the United States Food and Drug Administration (FDA) is expected to bolster the market growth. In March 2024, DiaSorin SpA received 510(k) clearance from the FDA for its new fully automated multiplexing platform LIAISON PLEX platform and its first panel of tests, LIAISON PLEX Respiratory Flex Assay. Through its innovative and cost-efficient multiplex molecular diagnostic platform, the company will gain access to the lucrative syndromic multiplexing market. The availability of such multiplexing platforms that maximize testing efficiencies in the laboratories is anticipated to boost the multiplexed diagnostics market share in the forecast period.
Other factors that are driving the market growth are the increased investment in genomic research from various sectors, rising healthcare expenditure, and the growing demand for personalized medicine. Moreover, the rising collaborations among the key market players are likely to accelerate the development of more sophisticated and advanced multiplexed diagnostic platforms.
"Global Multiplexed Diagnostics Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Geographically, the multiplexed diagnostics market report offers insights for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The regional disparity in the market growth relies on factors such as advancement in the healthcare infrastructure, the prevalence and incidence of diseases, and the adoption rate of multiplexed diagnostic technologies. North America leads the market segment, which can be attributed to the significant healthcare expenditure and the availability of advanced technologies in the healthcare facilities. Moreover, the increased investment by public and private sectors in the life science research is also expected to drive the market growth in the coming years.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 14.86 Billion in 2025 driven by the growing demand for advanced diagnostic technology across the globe.
The market is anticipated to grow at a CAGR of 15.20% during the forecast period of 2026-2035, likely to reach a market value of USD 61.17 Billion by 2035.
Technological advancements in the multiplexed diagnostic platform and the increased healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the surge in approvals of multiplexed diagnostic platforms by health regulatory agencies such as the United States Food and Drug Administration (FDA). In March 2024, DiaSorin SpA received FDA 510(k) clearance for its new fully automated multiplexing platform LIAISON PLEX platform and its first panel of tests, LIAISON PLEX Respiratory Flex Assay.
Based on the product, the market comprises instruments and accessories, along with consumables.
On the basis of technology, multiplexed diagnostics can be categorized as high-density multiplexed assays, medium density multiplexed assays, and low density multiplexed assays.
Major end users of multiplexed diagnostics include hospitals, diagnostic centers, and other healthcare facilities
Applications of multiplexed diagnostics can be found across infectious diseases, autoimmune diseases, cardiac diseases, oncology, and other medical conditions.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are DiaSorin S.p.A, Thermo Fisher Scientific Corporation, QIAGEN N.V., Siemens Healthineers, BioMerieux, Agilent Technologies Inc., F. Hoffmann La Roche Ltd., Illumina Inc., Hologic Inc., Co-Diagnostics, Inc., Abbott Laboratories, and Bio-Rad Laboratories Inc.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share